Viewing Study NCT07432295


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-31 @ 5:52 AM
Study NCT ID: NCT07432295
Status: RECRUITING
Last Update Posted: 2026-02-25
First Post: 2026-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Sponsor: I-Mab Biopharma US Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module